Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Holding SURI?
Track your performance easily
SURI Price & Analysis
SURI ETF Chart & Stats
Day’s Range― - ―
52-Week Range$16.89 - $26.08
Previous Close$22.59
VolumeN/A
Average Volume (3M)21.51K
AUM97.83M
NAV22.56
Expense Ratio2.51%
Holdings Count27
Beta0.81
Inception DateFeb 08, 2023
Last Dividend Ex-Date
Mar 25, 2024Dividend Yield
2.72 (―)Shares Outstanding2,920,001
Standard Deviation0.10
10 Day Avg. Volume974
30 Day Avg. Volume21,513
Alpha-0.02
Simplify Propel Opportunities ETF (SURI) Fund Flow Chart
Simplify Propel Opportunities ETF (SURI) 1 year Net Flows: $33M
SURI ETF News
SURI ETF FAQ
What was SURI’s price range in the past 12 months?
SURI lowest ETF price was $16.89 and its highest was $26.08 in the past 12 months.
What is the AUM of SURI?
As of May 09, 2024 The AUM of SURI is 97.83M.
Is SURI overvalued?
According to Wall Street analysts SURI’s price is currently Undervalued.
Does SURI pay dividends?
SURI pays a Quarterly dividend of $0.68 which represents an annual dividend yield of N/A. See more information on SURI dividends here
How many shares outstanding does SURI have?
SURI has 2,920,001 shares outstanding.
Which hedge fund is a major shareholder of SURI?
Currently, no hedge funds are holding shares in SURI
SURI ETF Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.
Top 10 Holdings
Plains GP Holdings LP
26.23%
Applied Therapeutics
13.42%
Tscan Therapeutics, Inc.
8.42%
Phathom Pharmaceuticals, Inc.
5.43%
Madrigal
4.97%
EQUITY OTHER
4.94%
U.S. Dollar
3.73%
Fulcrum Therapeutics
3.60%
Avidity Biosciences Inc
3.49%
Athira Pharma, Inc.
3.42%
Total77.65%
ETF Description
Simplify Propel Opportunities ETF
SURI employs an actively managed, multi-asset strategy that focuses on equity and debt securities of companies in the healthcare sector. The fund selects securities believed to be attractive investment opportunities. Derivatives may also be used to leverage exposure and hedge against declines.